Free tool
Stocks above their 200-day average
We cover 574 companies trading above their own 200-day average. The median market value in the group is $1.01B. Across the group, the median move over the past trading day is 0.00%. 100% of the 574 with a 200-day average trade above it. Price change over the past year runs from −11.5% to +178.1% across the middle 80 percent of the group, with a median of +32.6%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
574 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| STIL.ST | Stille AB | $216.03M | Small cap | −4.26% |
| DERM | Journey Medical Corporation | $212.95M | Small cap | +0.87% |
| CUE | Cue Biopharma, Inc. | $209.58M | Small cap | +16.42% |
| ANTX | AN2 Therapeutics, Inc. | $208.68M | Small cap | +385.09% |
| AOTI.L | AOTI, Inc. | $205.47M | Small cap | +159.09% |
| ACOG | Alpha Cognition Inc. | $204.93M | Small cap | +14.20% |
| ICE.WA | Medinice S.A. | $204.25M | Small cap | +595.19% |
| PDEX | Pro-Dex, Inc. | $203.83M | Small cap | +40.31% |
| 096760.KS | JW Holdings Corporation | $202.71M | Small cap | +28.35% |
| KRRO | Korro Bio, Inc. | $201.45M | Small cap | −36.61% |
| MSCL.TO | Satellos Bioscience Inc. | $199.95M | Small cap | +81.67% |
| PLX | Protalix BioTherapeutics, Inc. | $199.82M | Small cap | +55.00% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| AMWL | American Well Corporation | $199.17M | Small cap | +71.51% |
| MSLE | Satellos Bioscience Inc. | $198.59M | Small cap | +77.27% |
| NKTX | Nkarta, Inc. | $194.10M | Small cap | +17.41% |
| 5592.T | Kusurinomadoguchi, Inc. | $191.48M | Small cap | −27.59% |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% |
| PEB.AX | Pacific Edge Limited | $182.42M | Small cap | +60.00% |
| MYX.AX | Mayne Pharma Group Limited | $182.17M | Small cap | −37.38% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $180.64M | Small cap | +21.78% |
| 008490.KS | Suheung Co., Ltd. | $179.47M | Small cap | −24.62% |
| CARA.ST | Carasent AB (publ) | $178.28M | Small cap | −10.62% |
| 4320.T | CE Holdings Co.,Ltd. | $172.87M | Small cap | +139.84% |
| MOLN | Molecular Partners AG | $170.46M | Small cap | +18.67% |
| KZIA | Kazia Therapeutics Limited | $166.83M | Small cap | +86.94% |
| VME.DE | Viromed Medical AG | $164.76M | Small cap | +85.71% |
| FOCL | EDAP TMS S.A. | $164.75M | Small cap | +179.11% |
| NYKD.OL | Nykode Therapeutics AS | $160.76M | Small cap | +204.86% |
| OKUR | OnKure Therapeutics, Inc. | $155.52M | Small cap | +35.71% |
| 3939.T | Kanamic Network Co.,LTD | $154.86M | Small cap | +6.05% |
| ENE.WA | Centrum Medyczne ENEL-MED S.A. | $154.41M | Small cap | +16.28% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +103.46% |
| NRXP | NRx Pharmaceuticals, Inc. | $149.80M | Small cap | +34.11% |
| EQ | Equillium, Inc. | $149.64M | Small cap | +23.56% |
| MRC.WA | Mercator Medical S.A. | $148.80M | Small cap | +35.88% |
| BICO.ST | BICO Group AB (publ) | $147.45M | Small cap | −17.00% |
| GENO.ST | Genovis AB (publ.) | $146.60M | Small cap | −16.91% |
| V5P.F | Vytrus Biotech, S.A. | $146.35M | Small cap | +225.93% |
| LOVE.TO | Cannara Biotech Inc. | $141.63M | Small cap | +11.80% |
| 4599.T | StemRIM | $140.21M | Small cap | +14.75% |
| PAX.ST | Paxman AB (publ) | $139.52M | Small cap | −21.45% |
| MXCT | MaxCyte, Inc. | $139.33M | Small cap | −6.43% |
| HURA | TuHURA Biosciences, Inc. | $135.74M | Small cap | −26.55% |
| NYR.AX | Nyrada Inc. | $135.23M | Small cap | +210.20% |
| 7600.T | Japan Medical Dynamic Marketing, INC. | $134.12M | Small cap | +59.26% |
| SEDANA.ST | Sedana Medical AB (publ) | $132.45M | Small cap | −22.05% |
| MVIR.ST | Medivir AB (publ) | $131.70M | Small cap | +4.73% |
| XI3.F | Bioceltix S.A. | $131.58M | Small cap | −28.67% |
| 3649.T | FINDEX Inc. | $131.51M | Small cap | +4.84% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| PMN | ProMIS Neurosciences, Inc. | $129.67M | Small cap | +9.13% |
| VANI | Vivani Medical, Inc. | $127.64M | Small cap | +15.98% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% |
| 4538.T | Fuso Pharmaceutical Industries,Ltd. | $123.47M | Small cap | +11.15% |
| ANIX | Anixa Biosciences, Inc. | $122.65M | Small cap | +22.20% |
| CRAD-B.ST | C-Rad AB (publ) | $122.23M | Small cap | +6.49% |
| SCP.WA | Scope Fluidics S.A. | $120.06M | Small cap | −9.90% |
| EMV.AX | EMVision Medical Devices Ltd | $119.89M | Small cap | −13.93% |
| SDI.AX | SDI Ltd | $119.34M | Small cap | +60.41% |
| MDP.TO | Medexus Pharmaceuticals Inc. | $117.29M | Small cap | +66.56% |
| QUCY | Quantum Cyber N.V. | $115.59M | Small cap | −15.12% |
| SEER | Seer, Inc. | $112.96M | Small cap | −1.94% |
| SYNACT.ST | SynAct Pharma AB | $111.82M | Small cap | +10.82% |
| 3544.T | Satudora Holdings Co.,Ltd. | $108.01M | Small cap | +51.42% |
| ALECR.PA | Eurofins-Cerep SA | $107.03M | Small cap | −3.80% |
| HBP.TO | Helix BioPharma Corp. | $106.76M | Small cap | +46.97% |
| LNSR | LENSAR, Inc. | $106.27M | Small cap | −29.04% |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% |
| 7634.T | Hoshi Iryo-Sanki Co., Ltd. | $103.93M | Small cap | +14.22% |
| 4575.T | CanBas Co., Ltd. | $103.86M | Small cap | −30.98% |
| PYPD | PolyPid Ltd. | $103.79M | Small cap | +49.42% |
| PTHS | Pelthos Therapeutics Inc. | $102.53M | Small cap | +12.90% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.